Robert F. Kennedy, Jr, will lead the nation’s largest health and human services agency after today’s US Senate vote. Many ...

Purpose: The clinical benefits, adverse effects, pharmacokinetics, and recommendations for the appropriate use of the aldosterone antagonists spironolactone and eplerenone in patients with heart ...

As the population of child and adolescent athletes grows, a corresponding increase in the number of athletic-related injuries has been seen. It is commonly said that children are not just "small ...

An exanthem is any eruptive skin rash that may be associated with fever or other systemic symptoms. Causes include infectious pathogens, medication reactions and, occasionally, a combination of both.

The Western Australian preterm birth prevention initiative: a whole of state singleton pregnancy cohort study showing the need to embrace alternative models of care for Aboriginal women.

Cough associated with acute and chronic respiratory conditions is common in patients of all ages. Levocloperastine is a novel antitussive with a pharmacological profile distinct from that of the ...

Medscape asked doctors to weigh in on which hospitals they love – ones where exceptional work environments, a commitment to patient care, and supportive leadership make them stand out.

Table III. Pharmacokinetic parameters for rebamipide following oral administration of granules or a tablet at a dose of 100mg in 27 healthy adult male volunteers [mean (SD)] ...

Women gaining >5% of baseline weight at 3 months were at higher risk of more weight gain at 1 year No follow-up of discontinuers; lack of nonhormonal control group [23] ...

Statins are a standard of care in many clinical settings such as acute myocardial infarction and for patients having or at risk of cardiovascular (CV) disease. This is based on a plethora of data ...

BACKGROUND: Both unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) are approved for venous thromboembolism (VTE) prophylaxis. Which agent is superior remains controversial.

Nat Clin Pract Endocrinol Metab. 2006;2(6):298-299. Clearly, dopamine agonists should not be withdrawn too early, and certainly not before completion of 12 months' treatment. Until more is known ...